Advisory Board December 3, 2024
The Biden administration last week proposed requiring Medicare and Medicaid to cover GLP-1 medications for weight loss, which would expand access to the drugs for millions of people. However, some lawmakers and healthcare groups have raised concerns about the costs of these weight-loss drugs, and it’s not clear what will become of the proposal with the incoming Trump administration.
5 catalysts that will impact the future of weight management drugs
CMS proposes coverage of weight-loss drugs
Last week, CMS proposed expanding coverage of weight-loss medications in Medicare and Medicaid programs. The change would allow 7.5 million people enrolled in Medicaid and Medicare to access the drugs.
“In recognition of the prevailing medical consensus that obesity is a disease, [CMS] is...
Today's Sponsors
Today's Sponsor